Suppr超能文献

Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study.

作者信息

Eriksson Anders, Flach Carl-Fredrik, Lindgren Anders, Kvifors Eva, Lange Stefan

机构信息

Department of Internal Medicine, Gastroenterology Unit, Sahlgren's University Hospital/Ostra, Göteborg, Sweden.

出版信息

BMC Gastroenterol. 2008 Aug 12;8:34. doi: 10.1186/1471-230X-8-34.

Abstract

BACKGROUND

The cause and pathophysiology of ulcerative colitis are both mainly unknown. We have previously used whole-genome microarray technique on biopsies obtained from patients with ulcerative colitis to identify 5 changed mucosal transcripts. The aim of this study was to compare mucosal expressions of these five transcripts in ulcerative colitis patients vs. controls, along with the transcript expression in relation to the clinical ulcerative colitis status.

METHODS

Colonic mucosal specimens from rectum and caecum were taken at ambulatory colonoscopy from ulcerative colitis patients (n = 49) with defined inflammatory activity and disease extension, and from controls (n = 67) without inflammatory bowel disease. The five mucosal transcripts aldolase B, elafin, MST-1, simNIPhom and SLC6A14 were analyzed using quantitative real-time PCR.

RESULTS

Significant transcript differences in the rectal mucosa for all five transcripts were demonstrated in ulcerative colitis patients compared to controls. The grade of transcript expression was related to the clinical disease activity.

CONCLUSION

The five gene transcripts were changed in patients with ulcerative colitis, and were related to the disease activity. The known biological function of some of the transcripts may contribute to the inflammatory features and indicate a possible role of microbes in ulcerative colitis. The findings may also contribute to our pathophysiological understanding of ulcerative colitis.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2d4/2531169/8162dd3826cb/1471-230X-8-34-1.jpg

相似文献

2
Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
Eur J Gastroenterol Hepatol. 2008 Apr;20(4):290-6. doi: 10.1097/MEG.0b013e3282f3557c.
3
Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening.
Inflamm Bowel Dis. 2006 Sep;12(9):837-42. doi: 10.1097/01.mib.0000232469.23574.11.
5
Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2017 Dec;23(12):2134-2141. doi: 10.1097/MIB.0000000000001252.
8
Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis.
Dis Colon Rectum. 2007 Sep;50(9):1384-92. doi: 10.1007/10350-007-0302-x.
9
Diagnostic difficulty arising from rectal recovery in ulcerative colitis.
J Clin Pathol. 1996 Apr;49(4):319-23. doi: 10.1136/jcp.49.4.319.
10
Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Hepatogastroenterology. 1999 Jul-Aug;46(28):2338-42.

引用本文的文献

1
Mammalian Tolerance to Amino Acid Heterochirality.
Chembiochem. 2025 Jul 11;26(13):e202500273. doi: 10.1002/cbic.202500273. Epub 2025 Jun 19.
2
Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease.
Medicina (Kaunas). 2024 Jul 31;60(8):1243. doi: 10.3390/medicina60081243.
3
Evaluating the significance of ECSCR in the diagnosis of ulcerative colitis and drug efficacy assessment.
Front Immunol. 2024 Aug 7;15:1426875. doi: 10.3389/fimmu.2024.1426875. eCollection 2024.
5
Elafin and its precursor trappin-2: What is their therapeutic potential for intestinal diseases?
Br J Pharmacol. 2023 Jan;180(2):144-160. doi: 10.1111/bph.15985. Epub 2022 Nov 28.
7
Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis.
Cell Mol Life Sci. 2020 Sep;77(17):3311-3323. doi: 10.1007/s00018-020-03487-x. Epub 2020 Mar 12.

本文引用的文献

1
Review article: biological activity markers in inflammatory bowel disease.
Aliment Pharmacol Ther. 2007 Feb 1;25(3):247-55. doi: 10.1111/j.1365-2036.2006.03184.x. Epub 2007 Jan 8.
3
Recent understanding of IBD pathogenesis: implications for future therapies.
Inflamm Bowel Dis. 2006 Nov;12(11):1068-83. doi: 10.1097/01.mib.0000235827.21778.d5.
4
Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening.
Inflamm Bowel Dis. 2006 Sep;12(9):837-42. doi: 10.1097/01.mib.0000232469.23574.11.
5
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407. doi: 10.1038/ncpgasthep0528.
6
Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002.
Eur J Gastroenterol Hepatol. 2006 Jun;18(6):601-6. doi: 10.1097/00042737-200606000-00005.
8
Immunity, inflammation, and allergy in the gut.
Science. 2005 Mar 25;307(5717):1920-5. doi: 10.1126/science.1106442.
9
Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa.
FEBS Lett. 2004 Mar 12;561(1-3):122-6. doi: 10.1016/S0014-5793(04)00139-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验